New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Research sheds important light on the metastasis of neuroblastoma

Research sheds important light on the metastasis of neuroblastoma

by Paul Wiggins, Children's Cancer Institute AustraliaCredit: Children's Cancer Institute AustraliaNeuroblastoma can grow and spread in the body very aggressively, making it very difficult to
Oncology May 31,2024
Research sheds important light on the metastasis of neuroblastoma

Research sheds important light on the metastasis of neuroblastoma

by Paul Wiggins, Children's Cancer Institute AustraliaCredit: Children's Cancer Institute AustraliaNeuroblastoma can grow and spread in the body very aggressively, making it very difficult to
Oncology May 31,2024
Risk-taking behavior on roads in Victoria, Australia increased during lockdowns, study shows

Risk-taking behavior on roads in Victoria, Australia increased during lockdowns, study shows

by Monash UniversityCredit: Pixabay/CC0 Public DomainReduced travel on Victoria's roads during the COVID-19 pandemic did not equate to proportionate reductions in road trauma.New research&nbs
Oncology May 31,2024
Risk-taking behavior on roads in Victoria, Australia increased during lockdowns, study shows

Risk-taking behavior on roads in Victoria, Australia increased during lockdowns, study shows

by Monash UniversityCredit: Pixabay/CC0 Public DomainReduced travel on Victoria's roads during the COVID-19 pandemic did not equate to proportionate reductions in road trauma.New research&nbs
Oncology May 31,2024
Study details how exosomes, released by the breast tumor, tricks cells in the blood-brain barrier into taking them up

Study details how exosomes, released by the breast tumor, tricks cells in the blood-brain barrier into taking them up

by Children's Hospital BostonExtracellular vesicles, also known as exosomes, cross the blood-brain barrier via a transcytosis process. Credit: Kristin Johnson/Vascular Biology Program, Boston
Oncology May 31,2024
Study details how exosomes, released by the breast tumor, tricks cells in the blood-brain barrier into taking them up

Study details how exosomes, released by the breast tumor, tricks cells in the blood-brain barrier into taking them up

by Children's Hospital BostonExtracellular vesicles, also known as exosomes, cross the blood-brain barrier via a transcytosis process. Credit: Kristin Johnson/Vascular Biology Program, Boston
Oncology May 31,2024
Study sheds new light on the growth of bladder cancer

Study sheds new light on the growth of bladder cancer

by Curtin UniversityCredit: Curtin UniversityNew Curtin University-led research has discovered that using drugs to target a pathway in the body that causes cancerous cells to spread aggressively
Oncology May 31,2024
Study sheds new light on the growth of bladder cancer

Study sheds new light on the growth of bladder cancer

by Curtin UniversityCredit: Curtin UniversityNew Curtin University-led research has discovered that using drugs to target a pathway in the body that causes cancerous cells to spread aggressively
Oncology May 31,2024
Study shows how to make (and destroy) a metastatic cancer cell

Study shows how to make (and destroy) a metastatic cancer cell

by CU Anschutz Medical CampusColorado study shows that inhibiting the lysosomal stage of autophagy (and not necessarily the action of the autophagosome) may kill metastatic cancer cells. Credit:
Oncology May 31,2024
Study shows how to make (and destroy) a metastatic cancer cell

Study shows how to make (and destroy) a metastatic cancer cell

by CU Anschutz Medical CampusColorado study shows that inhibiting the lysosomal stage of autophagy (and not necessarily the action of the autophagosome) may kill metastatic cancer cells. Credit:
Oncology May 31,2024
Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a
Oncology May 31,2024
Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a
Oncology May 31,2024
Study provides new guidelines for assessing severity of head and neck cancers

Study provides new guidelines for assessing severity of head and neck cancers

by Cedars-Sinai Medical Center'The greater the number of malignant lymph nodes, the less favorable the patients' chances of survival,' said Allen S. Ho, MD. Ho is director of the Head
Oncology May 31,2024
Study provides new guidelines for assessing severity of head and neck cancers

Study provides new guidelines for assessing severity of head and neck cancers

by Cedars-Sinai Medical Center'The greater the number of malignant lymph nodes, the less favorable the patients' chances of survival,' said Allen S. Ho, MD. Ho is director of the Head
Oncology May 31,2024
Study shows importance of quality of life scores as prognostic factors in cancer patients

Study shows importance of quality of life scores as prognostic factors in cancer patients

by European Organisation for Research and Treatment of Cancer (EORTC)Credit: CC0 Public DomainCancer patients own reporting of their quality of life can be important in predicting the outcome of their
Oncology May 31,2024
Study shows importance of quality of life scores as prognostic factors in cancer patients

Study shows importance of quality of life scores as prognostic factors in cancer patients

by European Organisation for Research and Treatment of Cancer (EORTC)Credit: CC0 Public DomainCancer patients own reporting of their quality of life can be important in predicting the outcome of their
Oncology May 31,2024
Research raises hope for new therapies for chordoma, a rare bone cancer

Research raises hope for new therapies for chordoma, a rare bone cancer

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsChordoma is literally a one in a million cancer, with few effective treatment options. A new unde
Oncology May 31,2024
Research raises hope for new therapies for chordoma, a rare bone cancer

Research raises hope for new therapies for chordoma, a rare bone cancer

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsChordoma is literally a one in a million cancer, with few effective treatment options. A new unde
Oncology May 31,2024
The neural signature of subjective disgust could apply to both sensory and socio-moral experiences

The neural signature of subjective disgust could apply to both sensory and socio-moral experiences

by Ingrid Fadelli , Medical XpressSubjective disgust experience is associated with and predicted by distributed brain regions. a, Thresholded VIDS. b, Thresholded transformed VIDS 'activation patt
Psychiatry & Mental Health May 30,2024
The neural signature of subjective disgust could apply to both sensory and socio-moral experiences

The neural signature of subjective disgust could apply to both sensory and socio-moral experiences

by Ingrid Fadelli , Medical XpressSubjective disgust experience is associated with and predicted by distributed brain regions. a, Thresholded VIDS. b, Thresholded transformed VIDS 'activation patt
Psychiatry & Mental Health May 30,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com